The Effects of Conditioned Medium from Bone Marrow-derived Mesenchymal Stem Cells on EMT Markers
Archives of Advances in Biosciences,
Vol. 11 No. 2 (2020),
16 May 2020
Introduction: Epithelial-Mesenchymal Transition in colorectal cancer cell is a critical process in which cells lose their epithelial properties and obtain mesenchymal characteristics, resulting in tumor cells and metastasis. This study attempted to work on the effects of conditioned medium from bone marrow-derived mesenchymal stem cells on EMT markers.
Materials and Methods: In this study, HT29 was used which is the colorectal cancer cell line. Cells were treated for 72 hours with BMSC-CM in order to induce EMT in HT29. The Real-Time PCR was used for evaluating EMT markers such as E-cadherin- β-catenin -vimentin-and transcription factors.
Results: Inducing EMT in colorectal cancer cells caused morphological changes. It was manifested that E-cadherin is downregulated after induction of EMT with treated BMSC-CM. On the other hand, there were a significant increase in β-catenin, Vimentin, Snail and ZEB1 expression.
Conclusion: Understanding the molecular basis of tumor metastasis is critical for colorectal cancer treatment. Findings demonstrated morphological alterations in consequence MSCs-CM activates induction of EMT. This process affects EMT markers of E-cadherina, Vimentin, β-Catenin and transcription factors of Snail and ZEB1. This model helps knowing cancer and metastasis pathway and also could be used in drug screening procedures.
- Cancer stem cells
- colorectal cancer
- Epithelial-Mesenchymal Transition
- Mesenchymal Stem cell
- Conditioned Medium
- Bone marrow mesenchymal stem cell.
Iegel, R., K. Miller, and A. Jemal, Cancer statistics, 2018. CA Cancer J Clin, 2018 68(1): p. 7-30.
Iegel, R., et al., Colorectal cancer statistics,CA Cancer J Clin, 2017 67(3): p. 177-193.
Georgios, V., et al., Current Trends in the Surgical Management of Colorectal Cancer Liver Metastases. Curr Colorectal Cancer Rep, 2019.
Brenner, H., M. Kloor, and C. Pox, Colorectal cancer. Lancet 2013.
Manfredi, S. and et al., Bouvier, Epidemiology and management of liver metastases from colorectal cancer, Ann. Surg, 2006. 277: p. 254-259.
Trung, V., U. Pran, and K. Datta, Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis. Cancers, 2017.
Murat, K., Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene 2015. 567: p. 81-86.
Richard, C. and A. Bates, Colorectal Cancer Progression: Integrin alphavbeta6 and the Epithelial-Mesenchymal Transition (EMT). Cell Cycle, 2005 4(10): p. 1350-1352.
Heerboth, S., et al., EMT and tumor metastasis. Clin Transl Med 2015. 4(6).
Larue, L. and A. Bellacosa, Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3’ kinase/AKT pathways. Oncogene 2005. 24: p. 7443–5.
Boyer, B., A. Valles, and N. Edme, Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol, 2000. 60: p. 1091–1099.
Kang, Y. and K. Pantel, Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell, 2013. 13(2): p. 573-581.
Mathias, R., S. Gopal, and R. Simpson, Contribution of cells undergoing epithelial-mesenchymal transition to the tumor microenvironment. J Proteomics 2013. 78: p. 545-57.
Micalizzi, D., S. Farabaugh, and H. Ford, Epithelialmesenchymaltransition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia, 2010. 117: p. 15-34.
Marlena, B., et al., The role of Snail1 transcription factor in colorectal cancer progression and metastasis. Contemp Oncol (Pozn), 2015. 19 (4): p. 265–270.
Moreno-Bueno, G., et al., Genetic proﬁling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 2006. 66 (19): p. 9543-9556.
Bolos, V., et al., The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci, 2003. 116(3): p. 499-511.
Peinado, H., et al., Cano A Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci, 2004. 117(13): p. 2827-2839.
Dave, N., et al., Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem, 2011. 286(14): p. 12024-12032.
Casas, E., et al., Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 2011. 71(1): p. 245-254.
Gonzalez, D. and D. Medici, Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal, 2014: p. 7-8.
Kong, D., et al., Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins? Cancers 2011. 716: p. 3-29.
Ullah, I., R. Subbarao, and G. Rho, Human mesenchymal stem cells - current trends and future prospective. Biosci Rep, 2015. 3(1): p. 18.
Liang, X., et al., Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant, 2014. 23(59): p. 1045.
Glenn, J. and K. Whartenby, Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World J Stem Cell, 2014. 6: p. 526.
Ueno, T., et al., Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-b1 signaling. Kidney Int 2013. 84(307): p. 297.
Liu, B., et al., Human umbilical cord derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction. Nephrology (Carlton) 2017. 23: p. 728.
Huang, S., et al., Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice. Cryotherapy 2015. 17(31): p. 922.
Wu, Y., et al., Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. Int Wound J, 2014. 11(10): p. 701.
Qi, Y., et al., TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Investig Dermatol, 2014. 134(37): p. 526.
Azizi, P., S. Mazhari, and S. Tokhanbigli, Paracrine signals of mesenchymal stem cells induce epithelial to mesenchymal transition in gastric cancer cells. Gastroenterol Hepatol Bed Bench, 2019. 12(1): p. 51-57.
Lee, W., et al., Apamin inhibits hepatic fibrosis through suppression of transforming growth factor β1-induced hepatocyte epithelial– mesenchymal transition. Biochem Biophys Res Commun, 2014. 450(13): p. 195-201.
Kozdon, K., et al., Mesenchymal Stem Cell–Like Properties of Orbital Fibroblasts in Graves' Orbitopathy. Invest Ophthalmol Visual Sci, 2015. 56: p. 5743-5750.
Torsvik, A. and R. Bjerkvig, Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev 2013. 39: p. 180-188.
Voulgari, A. and A. Pintzas, Epithelial–mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta Rev Cancer, 2009. 1796: p. 75-90.
Hardiany, N., Y. Yohana, and W. S. The impact of conditioned medium of umbilical cord-derived mesenchymal stem cells toward apoptosis and proliferation of glioblastoma multiforme cells. in IOP Conference Series: Earth and Environmental Science. 2019.
Caterson, E., et al., Human marrow-derived mesenchymal progenitor cells. MolBiotechnol 2002. 20: p. 245-256.
Gheldof, A., et al., Evolutionary functional analysis and molecular regulation of the ZEB transcription factors. Cell Mol Life Sci 2012. 69(15): p. 2527-2541.
Wang, J., et al., Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007(7138): p. 882-887.
Grooteclaes, M. and S. Frisch, Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000. 19(33): p. 3823-3828.
Comijn, J., et al., The two-handed E box binding zinc ﬁnger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell Biol, 2000. 7(6): p. 1267-1278.
Aigner, K., et al., The transcription factor ZEB1 (dEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007. 26(49): p. 6979-6988.
Vandewalle, C., et al., SIP1/ ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 2005. 33(20): p. 6566-6578.
Vandewalle, C., F. Van Roy, and G. Berx, The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci, 2009. 66(5): p. 773-787.
Brabletz, S. and T. Brabletz, The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep, 2010. 11(9): p. 670-677.
Lu, Y., et al., The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther 2008. 7: p. 245-251.
Dasari, V., et al., Downregulation of Focal Adhesion Kinase (FAK) by cord blood stem cells inhibits angiogenesis in glioblastoma. Aging 2010. 2: p. 791.
Clarke, M., F. Imhoff, and S. Baird, Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase 1 and 2. Mol Carcinog 2015. 54: p. 1214-1219.
Rhee, K., J. Lee, and Y. Eom, Mesenchymal stem cellmediated effects of tumor support or suppression. Int J Mol Sci 2015. 16: p. 30015-30033.
Ridge, S., F. Sullivan, and S. Glynn, Mesenchymal stem cells: Key players in cancer progression. Mol Cancer, 2017 16(1): p. 1-10.
- Abstract Viewed: 0 times
- PDF Downloaded: 0 times